Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
The patent covers a new method of use for Certepetide in treating pancreatic cancer and other solid tumors.
Lisata Therapeutics, Inc. (Nasdaq: LSTA) announced that the United States Patent and Trademark Office has granted a new method of use patent for Certepetide. This patent specifically covers the use of Certepetide in the treatment of pancreatic cancer and other solid tumors.
The granting of this patent strengthens Lisata Therapeutics' intellectual property portfolio and underscores the potential therapeutic applications of Certepetide in oncology.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.